nab-Paclitaxel in patients with advanced solid tumors and hepatic dysfunction: a pilot study

医学 紫杉醇 肝功能不全 紫杉醇 肝功能不全 内科学 肿瘤科 重症监护医学 药理学 化疗
作者
M. Biakhov,G. Kononova,José Iglesias,Neil Desai,Paul Bhar,Anita N. Schmid,Sibylle Loibl
出处
期刊:Expert Opinion on Drug Safety [Taylor & Francis]
卷期号:9 (4): 515-523 被引量:14
标识
DOI:10.1517/14740338.2010.487063
摘要

This pilot open-label clinical study evaluated the safety and pharmacokinetics of albumin-bound paclitaxel (nab-paclitaxel) in patients with advanced solid tumors and hepatic dysfunction.Dosing was determined according to baseline bilirubin levels as described in the package insert for Taxol((R)) (paclitaxel), and patients received 130, 200 or 260 mg/m(2) nab-paclitaxel every 3 weeks.Thirty patients with elevated baseline bilirubin and aspartate aminotransferase levels received nab-paclitaxel. The most commonly-occurring grade 3/4 adverse events were neutropenia and fatigue. Grade 3/4 neutropenia occurred in 10, 30 and 30% of patients receiving 130, 200 and 260 mg/m(2) nab-paclitaxel, respectively. Grade 3 fatigue presented in 50 and 30% patients receiving 130 and 200 mg/m(2) nab-paclitaxel, respectively (no grade 4 event). Only one (10%) patient had a grade 3 sensory neuropathy in the 260 mg/m(2) nab-paclitaxel arm. Treatment-related grade 3 bilirubinemia and elevated aspartate aminotransferase was observed in patients receiving 130 mg/m(2) (30 and 10%, respectively) and 260 mg/m(2) nab-paclitaxel (20 and 10%, respectively). One patient had a grade 4 bilirubinemia in the 200 mg/m(2) nab-paclitaxel arm. Total bilirubin levels were inversely correlated to paclitaxel clearance (p < 0001).nab-Paclitaxel has an acceptable tolerability profile in patients with solid tumors and hepatic dysfunction. The safety and pharmacokinetic results support the same dose modification scheme recommended for cremophor-based paclitaxel.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sanyecai发布了新的文献求助10
1秒前
1秒前
3秒前
3秒前
Volcano发布了新的文献求助10
4秒前
5秒前
星辰大海应助拓小八采纳,获得10
6秒前
Tao发布了新的文献求助10
7秒前
7秒前
Tangviva1988发布了新的文献求助10
7秒前
阳光沛柔发布了新的文献求助10
8秒前
SYLH应助cyn0762采纳,获得30
9秒前
13秒前
打打应助Tine采纳,获得30
14秒前
研友_VZG7GZ应助EED采纳,获得10
15秒前
缥缈问柳应助wjw采纳,获得10
15秒前
DijiaXu应助朝朝采纳,获得10
17秒前
sanyecai完成签到,获得积分10
17秒前
李健的小迷弟应助高铭泽采纳,获得10
20秒前
Zsl121完成签到,获得积分10
21秒前
21秒前
爆米花应助肖肖采纳,获得10
22秒前
22秒前
冬至完成签到,获得积分10
23秒前
24秒前
shenzhou9完成签到,获得积分10
24秒前
量子星尘发布了新的文献求助10
24秒前
25秒前
lll完成签到,获得积分20
27秒前
欣喜豌豆完成签到,获得积分10
29秒前
彭于晏应助雨过天晴采纳,获得10
29秒前
李健的小迷弟应助唐_采纳,获得10
30秒前
云辞忧发布了新的文献求助10
30秒前
华仔应助Livrik采纳,获得10
30秒前
EED发布了新的文献求助10
31秒前
32秒前
33秒前
34秒前
赘婿应助hhhi采纳,获得10
34秒前
领导范儿应助康康采纳,获得10
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035